How Long Should Procyanidin Be Used Before Seeing Visible Improvements in Hair Volume or Density?

Procyanidins are plant-derived polyphenols commonly found in foods such as apples, grapes, and cocoa. In recent years, their possible effects on hair growth have drawn attention within the scientific and cosmetic communities. The question of how long Procyanidin must be used before noticeable improvements in hair volume or density appear is not merely practical—it goes to the heart of how this compound interacts with the biology of hair follicles. The published human trials measured their main results at four and six months, with one continuing to twelve months, so a realistic expectation is that any change would take at least that long. However, these findings should be interpreted with caution, given the limitations in study design and participant diversity.

Hair follicles follow a cyclic growth pattern composed of three main stages: anagen (growth), catagen (transition), and telogen (rest). Researchers propose that procyanidin prolongs the anagen phase and keeps follicular cells in the growth state for longer. Because each follicle has its own cycle, changes in hair density or thickness typically require several months before they can be observed with the naked eye.

Reviewing the Evidence: What Research Has Shown

A small number of studies, all from the same Japanese research group at Kyowa Hakko Kogyo, have examined the effects of procyanidin B-2 on hair growth. That single-source, industry-funded origin is itself a limitation, along with the small sample sizes and short durations, so the results should be read conservatively.

The first human test was reported by Kamimura and colleagues in 2000 in Phytomedicine. It was a double-blind, placebo-controlled trial in 29 men — 19 applying a 1% procyanidin B-2 tonic and 10 applying placebo — over six months. Hair was assessed by macrophotography of a marked 0.25 cm² scalp area plus measurement of the diameter of clipped hairs. The procyanidin group gained an average of 6.68 hairs in that area against 0.08 in the placebo group, and gained more terminal hairs (defined as over 60 µm in diameter). The authors reported no adverse side effects in either group.

A second trial by Takahashi and colleagues in 2001, published in Phytotherapy Research, used the same 1% tonic and the same 19-versus-10 split, but over four months. In that trial, 78.9% of the procyanidin group showed an increase in mean hair diameter compared with 30.0% of the placebo group, and total hair count in the marked area rose by 3.67 in the procyanidin group while falling by 2.54 in the placebo group. Again, the authors reported no adverse side effects. A third trial by the same company, reported by Takahashi and colleagues in 2005 in the Journal of Cosmetic Dermatology, used a 0.7% apple procyanidin oligomer lotion in 43 men (21 procyanidin, 22 placebo). After six months, total hairs in a 0.5 cm² area had risen by 3.3 in the procyanidin group and fallen by 3.6 in the placebo group. The procyanidin group then continued to 12 months in total, and the authors reported further improvement over that time; there was no placebo comparison for months 7 to 12. All three trials were small, ran in men only, and were conducted by the company that identified the compound. A 2022 Turkish trial (Yeniay and Arca) tested a spray that combined procyanidin B-2 with biotin and dexpanthenol for 16 weeks, so its results cannot be credited to procyanidin alone.

Complementing these human studies, Takahashi and colleagues (1999) tested procyanidin B-2 and C-1 in mice in the Journal of Investigative Dermatology. Topical application of 1% procyanidin oligomers to shaven mice in the telogen phase produced significantly more hair regeneration than the vehicle alone. The findings support the hypothesis that procyanidin acts on follicular cells directly, though results from animal models cannot be automatically extrapolated to humans.

Mechanisms of Action: Why the Process Takes Months

Procyanidin's proposed mechanism comes from the same laboratory work. Takahashi and colleagues (2000) reported that several selective protein kinase C (PKC) inhibitors, including procyanidins, promote hair growth in laboratory models — PKC being a signalling molecule implicated in the hair cycle. Kamimura and colleagues (2006) reported that procyanidin oligomers counteract TGF-beta1- and TGF-beta2-induced apoptosis in hair epithelial cells, that is, they protected those cells in culture from a signal that pushes follicles out of the growth phase.

These are cell-level effects observed in the laboratory. Even if they hold in the human scalp, they would act through the hair cycle, which is why any visible change would follow months rather than weeks after starting.

A Critical Perspective: Limitations and Comparisons

The available studies on procyanidin's role in hair growth share several limitations. The three procyanidin-only trials lasted four to twelve months and involved 29, 29 and 43 men (101 in total), and all of that work comes from one industry group. The absence of large-scale, independent, multiethnic, or long-duration studies means that current conclusions are preliminary. Furthermore, the studies have focused entirely on men with androgenetic alopecia, leaving no data on women or on other types of hair loss such as telogen effluvium or alopecia areata.

Compared with approved treatments like finasteride and minoxidil, procyanidin remains an experimental cosmetic ingredient rather than a regulated drug. The U.S. Food and Drug Administration (FDA) has not approved it for the treatment of hair loss. Finasteride and minoxidil have undergone extensive clinical testing and regulatory review, while procyanidin research is still at an early stage and has not moved beyond three small trials from one company. All three trials state that no adverse side effects were observed, but three small trials in 101 men in total are not enough to establish a safety profile.

Procyanidin's proposed mechanism also differs from minoxidil's. Minoxidil is understood to act partly by improving blood flow to the scalp; the procyanidin work points instead at signalling inside the follicle. No study has compared the two directly, so this is a difference in proposed mechanism, not a demonstrated difference in effect.

What This Means for Individuals Using Procyanidin

Anyone trying procyanidin should set expectations against those trials: they measured their main results at four and six months, so a judgement made at week six has nothing to compare itself with. Because effects would depend on the natural rhythm of hair growth cycles, stopping early makes it impossible to tell whether the product did anything. Patience, consistency, and realistic expectations are central when evaluating results.

While the early findings are of interest, the evidence remains limited to three small industry trials and supporting laboratory work. More robust, longer-term, independent human trials are needed to determine whether it works and to establish standardized formulations and dosages. For now, procyanidin is an experimental cosmetic approach, not a treatment. If you are losing hair, a doctor or pharmacist can tell you what is causing it and review anything you plan to use alongside a prescribed treatment.

References

Kamimura, A., Takahashi, T., & Watanabe, Y. (2000). Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent. Phytomedicine, 7(6), 529–536. PMID 11194183. https://pubmed.ncbi.nlm.nih.gov/11194183/

Takahashi, T., Kamimura, A., Yokoo, Y., Honda, S., & Watanabe, Y. (2001). The first clinical trial of topical application of procyanidin B-2 to investigate its potential as a hair growing agent. Phytotherapy Research, 15(4), 331–336. PMID 11406858. https://pubmed.ncbi.nlm.nih.gov/11406858/

Takahashi, T., Kamimura, A., Kagoura, M., Toyoda, M., & Morohashi, M. (2005). Investigation of the topical application of procyanidin oligomers from apples to identify their potential use as a hair-growing agent. Journal of Cosmetic Dermatology, 4(4), 245–249. PMID 17168871. https://pubmed.ncbi.nlm.nih.gov/17168871/

Yeniay, Y., & Arca, E. (2022). Evaluation of the efficacy and safety of topical procyanidin B2 and placebo in the treatment of androgenetic alopecia in men: A randomized, double-blind, placebo-controlled study. Turkish Journal of Dermatology, 16(4), 108. https://doi.org/10.4103/tjd.tjd_41_22

Takahashi, T., Kamiya, T., Hasegawa, A., & Yokoo, Y. (1999). Procyanidin oligomers selectively and intensively promote proliferation of mouse hair epithelial cells in vitro and activate hair follicle growth in vivo. Journal of Investigative Dermatology, 112(3), 310–316. PMID 10084307. https://pubmed.ncbi.nlm.nih.gov/10084307/

Takahashi, T., Kamimura, A., Shirai, A., & Yokoo, Y. (2000). Several selective protein kinase C inhibitors including procyanidins promote hair growth. Skin Pharmacology and Applied Skin Physiology, 13(3–4), 133–142. PMID 10859531. https://pubmed.ncbi.nlm.nih.gov/10859531/

Kamimura, A., Takahashi, T., & Morohashi, M. (2006). Procyanidin oligomers counteract TGF-beta1- and TGF-beta2-induced apoptosis in hair epithelial cells: an insight into their mechanisms. Skin Pharmacology and Physiology, 19(5), 259–265. PMID 16778458. https://pubmed.ncbi.nlm.nih.gov/16778458/